Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers.

Authors Yarmolinsky J, Díez-Obrero V, Richardson TG. et al
Citation Plos Medicine. 2022 Feb; 19(2): e1003897.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/35113855/
PMCID PMC8812899

Read this next

Mayo Clinic study shows AI may improve prediction of colorectal cancer